Bionano Genomics, Inc. (BNGO) Operating income 2017–2025
Bionano Genomics, Inc. (BNGO) annual operating income history from SEC filings — each fiscal year as reported.
-$33.3MFY2025 · since FY2017: -$23.2M → -$33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.3M | +67.9% |
| FY2024 | -$104.0M | +51.7% |
| FY2023 | -$215.2M | -63.4% |
| FY2022 | -$131.7M | -70.8% |
| FY2021 | -$77.1M | -100.0% |
| FY2020 | -$38.6M | -49.0% |
| FY2019 | -$25.9M | -26.7% |
| FY2018 | -$20.4M | +12.1% |
| FY2017 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice